All AbMole products are for research use only, cannot be used for human consumption.
Muvalaplin (LY3473329) is a first-in-class, orally active lipoprotein (a) (Lp(a)) inhibitor that inhibits Lp(a) formation by blocking apolipoprotein apo(a)-apo B100 interactions and avoids interaction with the cognate protein fibrinogen. In addition, Muvalaplin is used in the study of cardiovascular and metabolism-related diseases.
Molecular Weight | 710.90 |
Formula | C42H54N4O6 |
CAS Number | 2565656-70-2 |
Form | Solid |
Solubility (25°C) | DMSO 15 mg/mL (ultrasonic and adjust pH to 3 with 1M HCl) |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.